- Report
- July 2024
- 200 Pages
Global
From €4361EUR$4,949USD£3,782GBP
- Report
- April 2023
- 147 Pages
Global
From €4361EUR$4,949USD£3,782GBP
- Report
- July 2022
- 85 Pages
Global
From €1762EUR$2,000USD£1,529GBP
- Report
- June 2022
- 43 Pages
Global
From €1762EUR$2,000USD£1,529GBP
- Report
- June 2022
- 43 Pages
Global
From €1762EUR$2,000USD£1,529GBP
- Report
- February 2022
- 106 Pages
Global
From €1762EUR$2,000USD£1,529GBP
- Report
- December 2023
- 80 Pages
United States
From €1322EUR$1,500USD£1,146GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1322EUR$1,500USD£1,146GBP
From €1322EUR$1,500USD£1,146GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1322EUR$1,500USD£1,146GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1322EUR$1,500USD£1,146GBP
- Report
- December 2023
- 80 Pages
Russia
From €1322EUR$1,500USD£1,146GBP
- Report
- December 2023
- 80 Pages
Poland
From €1322EUR$1,500USD£1,146GBP
- Report
- December 2023
- 80 Pages
India
From €1322EUR$1,500USD£1,146GBP
- Report
- December 2023
- 80 Pages
Germany
From €1322EUR$1,500USD£1,146GBP
- Report
- December 2023
- 80 Pages
France
From €1322EUR$1,500USD£1,146GBP
- Report
- December 2023
- 80 Pages
China
From €1322EUR$1,500USD£1,146GBP
- Report
- December 2023
- 180 Pages
Global
From €2203EUR$2,500USD£1,911GBP
From €1322EUR$1,500USD£1,146GBP
- Report
- May 2023
- 80 Pages
South Korea
From €1322EUR$1,500USD£1,146GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more